Novartis has announced that the US Food and Drug Administration has gr...
Zydus Cadila has received the final approval from the USFDA to market ...
Sanofi and Regeneron Pharmaceuticals, Inc. have restructured their glo...
Holmusk became a resident company of Johnson & Johnson Innovation,...
Lupin has announced that the European Commission has approved NaMuscla...
Vyome Therapeutics Inc, a clinical-stage specialty pharmaceutical comp...
Lupin Pharmaceuticals is voluntarily recalling 5 lots of Ceftriaxone f...
Pharma major Lupin has announced that it has received approval for its...
Respiratory diseases are the second leading cause of death in the popu...
HealthCare atHOME (HCAH) has announced that it has been certified as a...
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fer...
In a first of its kind collaborative initiative in India between a pha...
Drug firm Alembic Pharmaceuticals has said that it has received approv...
Hetero, India’s leading generic pharmaceutical companies and the...
Shilpa Medicare has announced that it has received approval from the U...
Nuvo Pharmaceuticals Inc. a globally focused, Canadian healthcare comp...
Pharma major Lupin announced that it has received approval for its Clo...
Ocular Therapeutix, a biopharmaceutical company focused on the formula...